Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

964 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-cell transcriptomics and epigenomics point to CD58-CD2 interaction in controlling primary melanoma growth and immunity.
Stubenvoll A, Schmidt M, Moeller J, Chango MAL, Schultz C, Antoniadou O, Loeffler-Wirth H, Bernhart S, Große F, Thier B, Paschen A, Anderegg U, Simon JC, Ziemer M, Schoeder CT, Binder H, Kunz M. Stubenvoll A, et al. Among authors: binder h. Cancer Commun (Lond). 2025 Jan 15. doi: 10.1002/cac2.12651. Online ahead of print. Cancer Commun (Lond). 2025. PMID: 39812166 No abstract available.
Methodological challenges using routine clinical care data for real-world evidence: a rapid review utilizing a systematic literature search and focus group discussion.
Pfaffenlehner M, Behrens M, Zöller D, Ungethüm K, Günther K, Rücker V, Reese JP, Heuschmann P, Kesselmeier M, Remo F, Scherag A, Binder H, Binder N; EVA4MII project. Pfaffenlehner M, et al. Among authors: binder h. BMC Med Res Methodol. 2025 Jan 14;25(1):8. doi: 10.1186/s12874-024-02440-x. BMC Med Res Methodol. 2025. PMID: 39810151 Free PMC article.
Opportunities, challenges and risks of using artificial intelligence for evidence synthesis.
Siemens W, von Elm E, Binder H, Böhringer D, Eisele-Metzger A, Gartlehner G, Hanegraaf P, Metzendorf MI, Mosselman JJ, Nowak A, Qureshi R, Thomas J, Waffenschmidt S, Labonté V, Meerpohl JJ. Siemens W, et al. Among authors: binder h. BMJ Evid Based Med. 2025 Jan 9:bmjebm-2024-113320. doi: 10.1136/bmjebm-2024-113320. Online ahead of print. BMJ Evid Based Med. 2025. PMID: 39788693 No abstract available.
Predicting cisplatin tolerability in older adults with head and neck cancer - Insights for improved chemoradiation outcomes.
Rühle A, Weymann M, Behrens M, Olbrich J, Kut C, Marschner SN, Haderlein M, Fabian A, Senger C, Bakst BP, Kraft J, von der Grün J, Looman EL, Chen E, Domschikowski J, Altay-Langguth A, Kalinauskaite G, Lewitzki V, Bonomi M, Blakaj D, Jhawar SR, Baliga S, Elguindy AN, Ferentinos K, Zamboglou C, Müller JA, Leucht C, Dickstein DR, Schnellhardt S, Haehl E, Hambsch P, Kuhnt T, Seidel C, Belka C, Mayer A, Schmidberger H, Grosu AL, Balermpas P, Stromberger C, Binder H, Quon H, Nicolay NH. Rühle A, et al. Among authors: binder h. Radiother Oncol. 2024 Dec 24;204:110697. doi: 10.1016/j.radonc.2024.110697. Online ahead of print. Radiother Oncol. 2024. PMID: 39725066 Free article.
Impact of mediastinal tumor burden and lymphatic spread in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial.
Gkika E, Dejonckheere CS, Sahlmann J, Barth SA, Schimek-Jasch T, Adebahr S, Hecht M, Miederer M, Brose A, Binder H, König J, Grosu AL, Nestle U, Rimner A. Gkika E, et al. Among authors: binder h. Radiother Oncol. 2024 Nov;200:110521. doi: 10.1016/j.radonc.2024.110521. Epub 2024 Sep 3. Radiother Oncol. 2024. PMID: 39236984 Clinical Trial.
964 results